Search results
Showing 436 to 450 of 879 results for community guidance
health settings and community or care home settings? Is there any particular benefit for black, Asian and minority ethnic...
effective and cost effective are interventions to support people in the community who are bereaved or affected by a suicide? Any...
Stakeholder registration: guidelines, quality standards and indicators
How to register as a stakeholder to help us develop guidelines, quality standards and indicators.
Stakeholder registration: guidelines, quality standards and indicators
How to register as a stakeholder to help us develop guidelines, quality standards and indicators.
Question Raising awareness about pelvic floor dysfunction: Are community-based strategies effective in raising awareness about the...
inequalities:- What are the barriers to and facilitators for increasing access to community pharmacy services by underserved groups? How...
NICE has developed a medtech innovation briefing (MIB) on InterDry for intertrigo .
How to register with us as a diagnostic technologies stakeholder.
How to register with us as a diagnostic technologies stakeholder.
Recommendation ID CG191/1 Question In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal...
Question Referral within a formal care pathway:- Is referral from a community pharmacy within a formal local care pathway framework more...
advice and education or behavioural support interventions delivered by community pharmacy teams to improve health and behavioural...
This guideline covers good practice for developing and updating local formularies in line with statutory requirements. It supports developing formularies that reflect local needs, reduce variation in prescribing, and allow rapid adoption of new medicines and treatments.
View recommendations for MPG1Show all sections
schemes that vary by: - setting – for example, home-based, gym-based, community-based or outdoors - intensity and duration – for...
TearLab osmolarity system for diagnosing dry eye disease (MIB47)
NICE has developed a medtech innovation briefing (MIB) on TearLab osmolarity system for diagnosing dry eye disease .